Medications suggested for second- and third-line treatments for diabetes management following treatment failure with metformin and sulfonylureas.
Read More »Yearly Archives: 2018
Poor Glycemic Management Equals Risk of Dementia
Patients with type 1 diabetes and prolonged increased HbA1c were found to be at two-times greater risk for dementia than those with well-managed HbA1c values.
Read More »Poor Understanding of Diabetes Therapy Leads to Increased Hba1c In Type 2 Diabetes
Thorough knowledge of anti-diabetes medications found to lead to better management, adherence.
Read More »Semaglutide May Foster Significant Weight Loss in Patients with Obesity
When combined with diet and exercise, GLP-1 medication showed significant weight loss compared to liraglutide and placebo, a new study finds.
Read More »GLP-1 Agonists Do Not Increase Risk for Diabetic Retinopathy
New findings compare treatment with patients taking two or more glucose-lowering agents.
Read More »Can Exercise Overcome Environmental Impacts like Pollution on Diabetes Risk?
By Sheri R. Colberg, PhD, FACSM
It's known that lack of exercise, poor eating habits, genetics, and lifestyle factors can all contribute to the onset of prediabetes and type 2 diabetes. I have spent many years touting the benefits of lifestyle change to prevent and manage these health conditions—and in some cases reverse them. Exercise is a particularly important lifestyle management tool because of its ability to lower inflammation (the underlying cause of insulin resistance) naturally.
CGM Studies
In your experience, what have most studies about CGM demonstrated?
- HbA1c is lower in CGM users regardless of age or type of insulin delivery.
- Patients using MDI + CGM have greater reductions in HbA1c than those using CSII + CGM.
- Reductions in glycemic variability and time spent in hypoglycemia are not significantly different between SAP and MDI/RT-CGM therapy groups.
- All of the above
Follow the link to see how you and your colleagues compare.
Read More »SGLT-2 Side Effects
Which is not a side effect of SGLT-2 Inhibitors?
A. Kidney failure
B. Hyperkalemia
C. Ketoacidosis
D. Hypertension
E. Increased cholesterol levels
F. Serious urinary tract infections
G. Increased bladder cancer risk
H. Serious allergic reactions
Follow the link for the answer.
Read More »iFORA Diabetes Manager
iFORA - Diabetes Manager app designed to make busy lives easier to manage. iFORA comes with advanced mobile technology, sleek interface design, detailed and yet careful data management tools to assist you in better diabetes management. The easy-to-use tools can help you better understand how your blood glucose level interlinks with a positive self-monitoring process through recording, tracking, seeing your diabetes information in statistic trend graphs, target pie charts and exporting data to Fora TeleHealth solution to share with your doctor.
Read More »Best Practices for Congenital Adrenal Hyperplasia Updated
Recommendations address screening, treatment approaches and emphasize shared decision making
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.